// App-Quantinova.ai

1139-087 : OPTIMIZING CROSSOVER FROM TICAGRELOR TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: THE CAPITAL OPTI-CROSS RANDOMIZED TRIAL

Researchers

Presenter

  • Ali Pourdjabbar

Principal Investigators

  • Benjamin Hibbert

  • Trevor Simard

  • F Daniel Ramirez

  • Peter Lugomirski

  • Ronnen Maze

  • Marino Labinaz

  • Aun-Yeong Chong

  • Alexander Dick

  • Chris Glover

  • Michael Froeschl

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved